Join Terrence Kenakin as he presents a two-day Applied course on September 21 and September 22 at 10AM CDT.
This two-day course will introduce the topic of biologics as a drug therapy in addition to recombinant replacement protein biologics, peptide signalling, immunotherapy, antibodies features, and nucleotide-based therapies. The unique safety concerns associated with biologics and the challenges of pharmacokinetics will also be discussed.
Terrence Kenakin received his doctorate in pharmacology from the University of Alberta (Edmonton, Canada) and joined The Burroughs Wellcome Fund (Research Triangle Park, NC, USA) where he spent seven years working in drug discovery. He then spent the next 25 years at GlaxoSmithKline before moving to the University of North Carolina School of Medicine where he has been a professor of pharmacology for the past six years. He has authored 10 books in the field of pharmacology and serves as the current Editor-in-Chief of the Journal of Receptors and Signal Transduction.
Image credit: Bill Oxford